We will participate in BIOEUROPE SPRING to meet our Biotech partners and build new relationships in the biopharmaceutical industry.
KINSY, Spanish CMO for Drug Substances and Intermediates (at clinical and commercial scales). Please, contact our team to schedule a meeting!
Partnering for Innovation at Bio-Europe Spring 2024 KINSY
The pharmaceutical market demands flexible manufacturing, robust regulatory compliance, and high technical expertise. In this regard, the presence of Bio-Europe Spring 2024 KINSY highlights our commitment to delivering tailored CDMO services. Consequently, we assist our partners across every stage of development.
Likewise, our infrastructure and technical capability allow us to execute complex synthetic projects. Therefore, at KINSY we offer the following core CDMO solutions:
- Custom Chemical Synthesis: We design and optimize synthetic routes tailored to specific client requirements and active molecule scale-up.
- cGMP API Manufacturing: We adhere to strict quality and analytical controls to ensure maximum purity and full regulatory compliance.
- Process Scaling & Pilot Production: We seamlessly transition chemical processes from lab scale to industrial manufacturing volume.
Connecting Global Pharma and CDMO Capabilities
Through our active involvement at Bio-Europe Spring 2024 KINSY reinforces its role as a trusted European partner. Therefore, we remain committed to driving progress across global healthcare and contract development initiatives.
If you want to discover more about our manufacturing capabilities or custom synthesis solutions, feel free to explore our product catalog. You can also directly contact our technical team.
Finally, to learn more about event highlights and networking details, you can visit the official Bio-Europe Spring website
